Trials / Unknown
UnknownNCT05129956
Sonoguided-microwave Uterine Myoma
Efficacy Evaluation of Laparoscopic Sonoguided-microwave Uterine Myoma Ablation
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Kaohsiung Medical University Chung-Ho Memorial Hospital · Academic / Other
- Sex
- Female
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
This study mainly evaluates the resolution of uterine fibroids by microwave ablation. The medical equipment used is Ke Hui. "The Ampening ablation system is a percutaneous surgery. During laparoscopic surgery, it is directly ablated and soft, including problems that cannot be solved by partial or complete tissue ablation. "Hydrogen is used. If the expected range of ablation can be found, there is no need to wait for 3 to 6 months for ablation slowly like Haifu surgery. A fast, small, high-quality treatment that provides reference for medical treatment and helps doctors choose the most suitable treatment.
Detailed description
A collection of 20 women suffering from uterine fibroids were treated with microwave fibroids ablation for symptoms of uterine fibroids, and they could be discharged the next day or two days after surgery. Schedule return visits and routine blood tests according to clinical needs, and follow up with ultrasound and questionnaires during routine return visits (1, 3, and 6 months) after surgery. In the third month after surgery, there will be another imaging report. Magnetic resonance imaging and blood tests are used to compare the changes of patients' fibroids, their physiological recovery status, and the degree of improvement in their quality of life.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | "Covidien" Emprint Ablation System with Thermosphere Technology | The ablation time and wattage are determined according to the size of the tumor. The wattages are respectively 45W, 75W, and 100W, and the maximum time is 10 minutes |
Timeline
- Start date
- 2021-08-06
- Primary completion
- 2024-06-30
- Completion
- 2024-12-31
- First posted
- 2021-11-22
- Last updated
- 2021-11-22
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT05129956. Inclusion in this directory is not an endorsement.